Home/Pipeline/CTC Automated Scanning and Detection

CTC Automated Scanning and Detection

Circulating Tumor Cells in blood

CommercialActive

Key Facts

Indication
Circulating Tumor Cells in blood
Phase
Commercial
Status
Active
Company

About Ikonisys

Founded in 2003 and headquartered in New Haven, USA, Ikonisys has established itself as a premier provider of automated FISH technology for oncology diagnostics. The company's core platform integrates automated microscopy, image analysis, and multiplexed assays to detect genetic alterations and rare circulating tumor cells with high sensitivity and specificity. By automating manual FISH processes, Ikonisys aims to increase lab throughput, reduce human error, and support the growing field of precision medicine. Its solutions target pathology labs seeking to standardize and scale complex genetic testing.

View full company profile

Therapeutic Areas